Cargando…

First‐line steroid treatment for spontaneous intracranial hypotension

BACKGROUND: Spontaneous intracranial hypotension (SIH) is a syndrome characterized by low cerebrospinal fluid (CSF) pressure and postural headaches, and affects 1 per 20,000 individuals every year. CASE REPORT: We report an otherwise healthy 38‐year‐old man admitted to the hospital with orthostatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonello, Simone, Grossi, Ugo, Trincia, Elena, Zanus, Giacomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303736/
https://www.ncbi.nlm.nih.gov/pubmed/35141990
http://dx.doi.org/10.1111/ene.15195
_version_ 1784751940932993024
author Tonello, Simone
Grossi, Ugo
Trincia, Elena
Zanus, Giacomo
author_facet Tonello, Simone
Grossi, Ugo
Trincia, Elena
Zanus, Giacomo
author_sort Tonello, Simone
collection PubMed
description BACKGROUND: Spontaneous intracranial hypotension (SIH) is a syndrome characterized by low cerebrospinal fluid (CSF) pressure and postural headaches, and affects 1 per 20,000 individuals every year. CASE REPORT: We report an otherwise healthy 38‐year‐old man admitted to the hospital with orthostatic headache that developed 48 h after a short‐haul flight during which he sustained a neck injury due to turbulence. Neurological examination, blood analysis and computed tomography scan performed at the emergency service were normal. Brain and spine magnetic resonance imaging (MRI) showed diffuse pachymeningeal enhancement and contrast medium egress from the subarachnoid space into the epidural space at the level of C2. The patient was treated with bed rest, hydration and 1 mg/kg/day oral prednisone for 5 days, with a gradual withdrawal in the following 7 days. Complete symptomatic relief was observed after 16 days, with resolution of the pathological findings on brain and spinal MRI after 1 month, except for localized pachymeningeal enhancement. Clinical relief was maintained over time until last follow‐up visit 9 months later. CONCLUSION: Successful conservative treatment barely exceeds one quarter of cases of SIH. The clinical benefits of steroids may result from several mechanisms of action, for example, improving brain oedema and inflammation, determining fluid retention, and facilitating reabsorption of the CSF from extradural space. Notwithstanding that epidural blood patch remains the most successful treatment for SIH, future studies should explore the effectiveness of steroids as first‐line therapy in addition to the most commonly suggested measures of bed rest and hydration.
format Online
Article
Text
id pubmed-9303736
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93037362022-07-28 First‐line steroid treatment for spontaneous intracranial hypotension Tonello, Simone Grossi, Ugo Trincia, Elena Zanus, Giacomo Eur J Neurol Headache BACKGROUND: Spontaneous intracranial hypotension (SIH) is a syndrome characterized by low cerebrospinal fluid (CSF) pressure and postural headaches, and affects 1 per 20,000 individuals every year. CASE REPORT: We report an otherwise healthy 38‐year‐old man admitted to the hospital with orthostatic headache that developed 48 h after a short‐haul flight during which he sustained a neck injury due to turbulence. Neurological examination, blood analysis and computed tomography scan performed at the emergency service were normal. Brain and spine magnetic resonance imaging (MRI) showed diffuse pachymeningeal enhancement and contrast medium egress from the subarachnoid space into the epidural space at the level of C2. The patient was treated with bed rest, hydration and 1 mg/kg/day oral prednisone for 5 days, with a gradual withdrawal in the following 7 days. Complete symptomatic relief was observed after 16 days, with resolution of the pathological findings on brain and spinal MRI after 1 month, except for localized pachymeningeal enhancement. Clinical relief was maintained over time until last follow‐up visit 9 months later. CONCLUSION: Successful conservative treatment barely exceeds one quarter of cases of SIH. The clinical benefits of steroids may result from several mechanisms of action, for example, improving brain oedema and inflammation, determining fluid retention, and facilitating reabsorption of the CSF from extradural space. Notwithstanding that epidural blood patch remains the most successful treatment for SIH, future studies should explore the effectiveness of steroids as first‐line therapy in addition to the most commonly suggested measures of bed rest and hydration. John Wiley and Sons Inc. 2022-02-09 2022-03 /pmc/articles/PMC9303736/ /pubmed/35141990 http://dx.doi.org/10.1111/ene.15195 Text en © 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Headache
Tonello, Simone
Grossi, Ugo
Trincia, Elena
Zanus, Giacomo
First‐line steroid treatment for spontaneous intracranial hypotension
title First‐line steroid treatment for spontaneous intracranial hypotension
title_full First‐line steroid treatment for spontaneous intracranial hypotension
title_fullStr First‐line steroid treatment for spontaneous intracranial hypotension
title_full_unstemmed First‐line steroid treatment for spontaneous intracranial hypotension
title_short First‐line steroid treatment for spontaneous intracranial hypotension
title_sort first‐line steroid treatment for spontaneous intracranial hypotension
topic Headache
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303736/
https://www.ncbi.nlm.nih.gov/pubmed/35141990
http://dx.doi.org/10.1111/ene.15195
work_keys_str_mv AT tonellosimone firstlinesteroidtreatmentforspontaneousintracranialhypotension
AT grossiugo firstlinesteroidtreatmentforspontaneousintracranialhypotension
AT trinciaelena firstlinesteroidtreatmentforspontaneousintracranialhypotension
AT zanusgiacomo firstlinesteroidtreatmentforspontaneousintracranialhypotension